Rasmus Holm Jorgensen Acrivon Therapeutics, Inc. (ACRV) insider trading activity

Shares Held (Direct Ownership) 26.5K

1.37% 3M change

5.48% 12M change

Total Value Held N/A

Rasmus Holm-Jorgensen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 14 2024	SELL Payment of exercise price or tax liability	$2,914 $7.92 p/Share	368 Reduced 1.37%	26,522 Common Stock
Aug 14 2024	SELL Payment of exercise price or tax liability	$2,583 $7.02 p/Share	368 Reduced 1.35%	26,890 Common Stock
May 14 2024	SELL Payment of exercise price or tax liability	$3,076 $8.36 p/Share	368 Reduced 1.33%	27,258 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$1,475 $3.4 p/Share	434 Reduced 1.55%	27,626 Common Stock
Nov 14 2023	SELL Payment of exercise price or tax liability	$7,467 $5.08 p/Share	1,470 Reduced 4.98%	28,060 Common Stock
Jun 16 2023	BUY Exercise of conversion of derivative security	$34,485 $3.63 p/Share	9,500 Added 24.34%	29,530 Common Stock
Nov 14 2022	BUY Grant, award, or other acquisition	-	20,030 Added 50.0%	20,030 Common Stock

Chief Financial Officer

Watertown, MA

Receive a notification when an Institution or Guru buys or sells ACRV shares.

Notify only if

Value

Get notified when an Acrivon Therapeutics, Inc. insider buys or sells ACRV shares.

Notify only if

Operation

Value

Type

Receive news related to Acrivon Therapeutics, Inc.